Compare GSK plc (GSK) vs Sunrun Inc (RUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Sunrun Inc — how do they compare? GSK plc trades at $52.8 (market cap $101.34B), while Sunrun Inc trades at $12.09 (market cap $3.05B). The key difference: GSK plc is far larger — about 33.2× Sunrun Inc's market cap, and GSK plc pays a 3.49% dividend while Sunrun Inc pays none. Which is the better fit depends on your goals.
| GSK | RUN | |
|---|---|---|
Market Cap | $101.34B | $3.05B |
Sector | Health | Technology |
52-Week High | $61.18 | $21.41 |
52-Week Low | $36.20 | $9.07 |
Enterprise Value | $121.95B | $17.24B |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
Sunrun (RUN) trades at $12.08, down 5.48% today, with a bearish technical signal. The stock shows strong fundamental valuation with a P/E of 6 and P/B of 0.91, while recent earnings consistently beat estimates. Positive news includes a major virtual power plant partnership with Tesla and Renew Home announced June 24, 2026, and a customer service award on July 16, 2026.
The outlook is mixed: analyst consensus is bullish with a $16.27 price target, but negative operating cash flow and high debt-to-asset ratio of 70.76% pose risks. The upcoming Q2 2026 earnings report on August 5, 2026, is a key catalyst for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →
